glp-1 sglt2 Criteria for recommendation of inhibitors or receptor Combining glucagon-like peptide-1 receptor agonists

A 15-amino-acid peptide based on a sequence from a protein found in the stomach Studied in rat research for its effects on the healing of tendon, muscle and gut tissue Investigated in cell and animal studies for its effects on blood-vessel growth and the nitric oxide pathway Studied for how it interacts with the body's own protective (prostaglandin) system For research use only

Chairman C.C

Some use peptides for 6-12 months to achieve a specific body composition goal, while those with chronic obesity may require long-term maintenance dosing to prevent metabolic relapse

Seefeldt T, Dwivedi C, Peitz G, Herman J, Carlson L, Zhang Z, et al